SPARK Neuro is advancing dementia detection and care with a payer-focused solution that identifies high-risk individuals early and enables proactive, specialist-led planning. With up to 40% of dementia cases undiagnosed, the company is closing a critical gap in care.
To prepare for its first national payer launch, SPARK Neuro partnered with MDisrupt to refine its go-to-market strategy, sharpen messaging, and accelerate commercialization with seasoned healthcare expertise
“We’re shining a light on brain health by proactively reaching undiagnosed dementia patients, especially those who may have been overlooked and guiding them into the care and support they need.”
— Marinela Gombosev, COO, SPARK Neuro
SPARK Neuro reached SPARK Neuro was at a pivotal growth stage where it realized that to get to its next stage of growth, execution on critical milestones was essential. To achieve this the team needed to:
“Recognizing our potential to transform dementia diagnosis, we sought out people who understood the nuances of the healthcare landscape and could guide us in making thoughtful decisions about our launch strategy.”
— Marinela Gombosev, COO, SPARK Neuro
Through MDisrupt’s marketplace, the company engaged two commercialization strategists with deep payer-market expertise. Working closely with leadership, these experts::
Together, they delivered:
“Working with MDisrupt helped us stay focused, make faster decisions, and ultimately deliver on our most important milestone.”
— Marinela Gombosev, COO, SPARK Neuro
Staying focused in a constantly shifting healthcare market requires expertise that’s often difficult to find. With support from MDisrupt’s experts, SPARK Neuro built clarity and confidence to keep growing and scaling while tackling critical challenges with precision.